Validation and Application of an Rapid HPLC–MS Method for the Determination of Salvianic Acid A in Human Plasma
Authors:
Open Access
- 24 September 2014
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 53 (5) , 771-777
Abstract
A rapid liquid chromatography–electrospray ionization-tandem mass spectrometry (LC–ESI–MS-MS) method was developed and validated for the determination of salvianic acid A in plasma of Chinese healthy subjects after oral administration of Qishenyiqi dropping pills. After liquid–liquid extraction with ethyl acetate, salvianic acid A was chromatographed on a Agilent Zorbax XDB-C18 column using a gradient mobile phase consisting of water (0.1% formic acid)–acetonitrile (0.1% formic acid) at a flow rate of 0.45 mL/min. The detection was performed in multiple reaction monitoring mode, using the transitions of m/z 196.9→134.8 and m/z 320.9→151.9 for salvianic acid A and chloroamphenicol, respectively. The method was linear over the range of 0.50–500 ng/mL using only 100 μL of plasma and the lower limit of quantification was 0.50 ng/mL. Intra-day and inter-day precisions (in terms of % RSD) were all Tmax and Cmax values were 1.33 ± 0.52 h and 21.1 ± 3.92 ng/mL, respectively. Plasma concentrations declined with t1/2Z of 1.76 ± 0.33 h.Keywords
This publication has 20 references indexed in Scilit:
- QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in RatsEvidence-Based Complementary and Alternative Medicine, 2013
- Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2Evidence-Based Complementary and Alternative Medicine, 2012
- Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plantsAnalytica Chimica Acta, 2011
- Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic–mass spectrometry and the application to pharmacokinetics in ratsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Characterization of the constituents in rat biological fluids after oral administration of Fufang Danshen tablets by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2009
- LC–MS determination and pharmacokinetic study of six phenolic components in rat plasma after taking traditional Chinese medicinal-preparation: Guanxinning lyophilized powder for injectionJournal of Chromatography B, 2008
- Metabolic analysis of four phenolic acids in rat by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2008
- Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfangJournal of Pharmaceutical and Biomedical Analysis, 2007
- Simultaneous determination and pharmacokinetic study of water‐soluble and lipid‐soluble components of danshen in rat plasma using HPLC‐UV methodBiomedical Chromatography, 2007
- Determination of Danshensu, a major active compound of Radix Salvia miltiorrhiza in dog plasma by HPLC with fluorescence detectionBiomedical Chromatography, 2001